跳至主要内容
临床试验/TCTR20171130004
TCTR20171130004已完成3 期

Comparison of the efficacy and safety using 0.01% vs 0.03% bimatoprost for the treatment of eyebrow hypotrichosis: A randomized, double-blind study

Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol0 个研究点目标入组 30 人开始时间: 2017年11月30日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • 1.Patients with eyebrow hypotrichosis
  • 2.Age more than 18 year-old
  • 3.No serious underlying diseases
  • 4.Informed consent
  • 5.Compatible with follow-up schedule

排除标准

  • 1.Patients undergone eyebrow transplantation
  • 2.Previously treated with drugs or products affecting eyebrow cycle within 2 wks
  • 3.Previously treated with minoxidil, systemic antiandrogen, topical estrogen/progesterone, topical prostaglandin analogs, anabolic steroids, lithium, phenothiazines
  • 4.Patients with underlying diseases involving eyebrow hypotrichosis eg. Cancer, immunocompromised, thyroid diseases or psychiatric disorders including trichotillomania
  • 5.Patients undergone eyebrow tattooing
  • 6.Patients with history of poor wound healing or with skin pathology on eyebrow
  • 7.Allergic to bimatoprost
  • 8.Pregnancy or lactation
  • 9.Withdraw

研究者

发起方
Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol

相似试验